Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
暂无分享,去创建一个
Ulrike Schick | Kevin J Harrington | Sarah L Gulliford | S. Bhide | K. Harrington | C. Nutting | S. Gulliford | U. Schick | K. Newbold | Kee H Wong | Shreerang A Bhide | Christopher M Nutting | J. Dean | K. Wong | L. Welsh | Ann-Britt Jones | Jamie A Dean | Liam C Welsh | Ann-Britt Jones | Kate L Newbold | Ann‐Britt Jones
[1] Dualta McQuaid,et al. Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] A Trotti,et al. Toxicity in head and neck cancer: a review of trends and issues. , 2000, International journal of radiation oncology, biology, physics.
[3] P. Lambin,et al. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] Johannes A Langendijk,et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Achim Zeileis,et al. Bias in random forest variable importance measures: Illustrations, sources and a solution , 2007, BMC Bioinformatics.
[6] J. Fowler,et al. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[8] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[9] Dale E. Berger,et al. On the inappropriateness of stepwise regression analysis for model building and testing , 2007, European Journal of Applied Physiology.
[10] A. E. Hoerl,et al. Ridge regression: biased estimation for nonorthogonal problems , 2000 .
[11] C. Gwede,et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] Alex H. S. Harris,et al. Common statistical and research design problems in manuscripts submitted to high-impact medical journals , 2011, BMC Research Notes.
[13] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[14] J. Habbema,et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.
[15] G. Sanguineti,et al. Predictors of PEG dependence after IMRT±chemotherapy for oropharyngeal cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Johannes A Langendijk,et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] A. van der Schaaf,et al. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] Gareth Ambler,et al. How to develop a more accurate risk prediction model when there are few events , 2015, BMJ : British Medical Journal.
[19] Ewout W Steyerberg,et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. , 2003, Journal of clinical epidemiology.
[20] S. Webb,et al. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] L. Peters,et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] P. Lambin,et al. Learning methods in radiation oncology ‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’ q , 2013 .
[23] M. Sormani,et al. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. , 2012, International journal of radiation oncology, biology, physics.
[24] J. Dewar,et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[26] S. Bhide,et al. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. , 2012, International journal of radiation oncology, biology, physics.
[27] S. Sonis. The pathobiology of mucositis. , 2004, Nature reviews. Cancer.
[28] R. Steenbakkers,et al. Late effects in head and neck radiotherapy Development of a multivariable normal tissue complication probability ( NTCP ) model for tube feeding dependence after curative radiotherapy / chemo-radiotherapy in head and neck cancer , 2014 .
[29] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[30] R. Mohan,et al. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] E. Yorke,et al. Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.
[32] Brian O'Sullivan,et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.
[33] H. Keselman,et al. Backward, forward and stepwise automated subset selection algorithms: Frequency of obtaining authentic and noise variables , 1992 .
[34] S. Bentzen. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology , 2006, Nature Reviews Cancer.
[35] S. Bhide,et al. A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes , 2014, British Journal of Cancer.
[36] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[37] K. Harrington,et al. A novel method for delineation of oral mucosa for radiotherapy dose–response studies , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] 高橋 聡,et al. Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .
[39] Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE) , 2003 .
[40] Steve Webb,et al. The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] G. Brier. VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY , 1950 .
[42] S. Bhide,et al. Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. , 2015, International journal of radiation oncology, biology, physics.
[43] J. Purdy,et al. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[44] Lawrence D. Jackel,et al. Learning Curves: Asymptotic Values and Rate of Convergence , 1993, NIPS.
[45] Johannes A Langendijk,et al. Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. , 2012, International journal of radiation oncology, biology, physics.
[46] J. Flickinger,et al. Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective. , 2015, International journal of radiation oncology, biology, physics.